Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng Cao

Showing results (521-530 of 1,100) with videos related to

Pageof 110
Sort By:
Journal of Microbiology and Biotechnology|October 13, 2022
Expression and Immunogenicity of SARS-CoV-2 Virus-Like Particles based on Recombinant Truncated HEV-3 ORF2 Capsid ProteinYong-Fei Zhou, Jiao-Jiao Nie, Chao Shi, et al.
Medicine|June 6, 2020
Efficacy of pirarubicin for nonmuscle invasive bladder cancer: A protocol of systematic review and meta-analysisDa-Yin Chen, Liang Cheng, Long-Xin Dong, et al.
Journal of Managed Care & Specialty Pharmacy|August 1, 2024
Health care resource utilization and direct costs incurred over 24 months after initiating galcanezumab or standard-of-care preventive migraine treatments in the United StatesOralee J Varnado, Michelle Vu, Erin Buysman, et al.
Phytochemistry|April 1, 2024
10-Secocycloartane (=9,19-cyclo-9,10-secolanostane) triterpenoid saponins: Huangqiyenins M-X from Astragalus membranaceus (Fisch.) BgeMeng-Qi Yan, Feng Xu, Hai-Xue Kuang, et al.
Bioorganic Chemistry|February 15, 2025
Insights into curcumin's anticancer activity in pancreatic ductal adenocarcinoma: Experimental and computational evidence targeting HRAS, CCND1, EGFR and AKT1Jun-Feng Cao, Xiao Zhang, Qingjie Xia, et al.
Experimental Cell Research|July 8, 2021
Partial inhibition of activin receptor-like kinase 4 alleviates bladder fibrosis caused by bladder outlet obstructionNing Wang, Lu Lu, Qi Feng Cao, et al.
Pesticide Biochemistry and Physiology|June 17, 2022
Virtual screening based on pharmacophore model for developing novel HPPD inhibitorsJia-Yu Wang, Shuang Gao, Juan Shi, et al.
Molecules (Basel, Switzerland)|June 10, 2017
3D Pharmacophore-Based Virtual Screening and Docking Approaches toward the Discovery of Novel HPPD InhibitorsYing Fu, Yi-Na Sun, Ke-Han Yi, et al.
Cell Death & Disease|February 5, 2020
Ferroptosis: past, present and futureJie Li, Feng Cao, He-Liang Yin, et al.
Medicine|June 3, 2020
Can docetaxel combined prednisone effectively treat hormone refractory prostate cancer?: A protocol of systematic review and meta-analysisLiang Cheng, Cai-Fang Yue, Yue Wang, et al.
Pageof 110

Showing results (521-530 of 1,100) with videos related to

Sort By:
Pageof 110
Journal of Microbiology and Biotechnology|October 13, 2022
Expression and Immunogenicity of SARS-CoV-2 Virus-Like Particles based on Recombinant Truncated HEV-3 ORF2 Capsid ProteinYong-Fei Zhou, Jiao-Jiao Nie, Chao Shi, et al.
Medicine|June 6, 2020
Efficacy of pirarubicin for nonmuscle invasive bladder cancer: A protocol of systematic review and meta-analysisDa-Yin Chen, Liang Cheng, Long-Xin Dong, et al.
Journal of Managed Care & Specialty Pharmacy|August 1, 2024
Health care resource utilization and direct costs incurred over 24 months after initiating galcanezumab or standard-of-care preventive migraine treatments in the United StatesOralee J Varnado, Michelle Vu, Erin Buysman, et al.
Phytochemistry|April 1, 2024
10-Secocycloartane (=9,19-cyclo-9,10-secolanostane) triterpenoid saponins: Huangqiyenins M-X from Astragalus membranaceus (Fisch.) BgeMeng-Qi Yan, Feng Xu, Hai-Xue Kuang, et al.
Bioorganic Chemistry|February 15, 2025
Insights into curcumin's anticancer activity in pancreatic ductal adenocarcinoma: Experimental and computational evidence targeting HRAS, CCND1, EGFR and AKT1Jun-Feng Cao, Xiao Zhang, Qingjie Xia, et al.
Experimental Cell Research|July 8, 2021
Partial inhibition of activin receptor-like kinase 4 alleviates bladder fibrosis caused by bladder outlet obstructionNing Wang, Lu Lu, Qi Feng Cao, et al.
Pesticide Biochemistry and Physiology|June 17, 2022
Virtual screening based on pharmacophore model for developing novel HPPD inhibitorsJia-Yu Wang, Shuang Gao, Juan Shi, et al.
Molecules (Basel, Switzerland)|June 10, 2017
3D Pharmacophore-Based Virtual Screening and Docking Approaches toward the Discovery of Novel HPPD InhibitorsYing Fu, Yi-Na Sun, Ke-Han Yi, et al.
Cell Death & Disease|February 5, 2020
Ferroptosis: past, present and futureJie Li, Feng Cao, He-Liang Yin, et al.
Medicine|June 3, 2020
Can docetaxel combined prednisone effectively treat hormone refractory prostate cancer?: A protocol of systematic review and meta-analysisLiang Cheng, Cai-Fang Yue, Yue Wang, et al.
Pageof 110